Glioblastoma Trials in Boston, United States
Conditions / Glioblastoma / Boston, United States
Glioblastoma has been the subject of sustained clinical investigation across multiple research sites.
111 total trials for this combination
Showing top 10 of 111 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02152982 | Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ACTIVE_NOT_RECRUITING | — |
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT00884741 | Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma | COMPLETED | PHASE3 |
| NCT01480479 | Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma | COMPLETED | PHASE3 |
| NCT04541225 | Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | TERMINATED | PHASE1 |
| NCT03581292 | Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT01723020 | A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma | COMPLETED | PHASE1 |
| NCT02327078 | A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) | COMPLETED | PHASE1/PHASE2 |
| NCT02152982 | Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ACTIVE_NOT_RECRUITING | — |
| NCT02573324 | A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification | COMPLETED | PHASE3 |